Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 16 (5) , 558-563
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and ImmunohistochemistryPLOS ONE, 2012
- National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in ChinaLung Cancer, 2012
- Detection of Epithelial Growth Factor Receptor Mutations in Cerebrospinal Fluid from Patients with Lung Adenocarcinoma Suspected of Neoplastic MeningitisJournal of Thoracic Oncology, 2011
- A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samplesJournal of Experimental & Clinical Cancer Research, 2010
- Brain metastases from lung cancer responding to erlotinib: the importance ofEGFRmutationEuropean Respiratory Journal, 2010
- Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasisLung Cancer, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task ForceEuropean Journal of Neurology, 2006
- Role of Stereotactic Radiosurgery in the Treatment of Brain MetastasesAmerican Journal of Clinical Oncology, 2005
- Detection of Tumor-derived DNA in Cerebrospinal FluidJournal of Neuropathology & Experimental Neurology, 1994